DISCLOSEDQuarterly
Oaktree Capital Management
Amphastar Pharmaceuticals Inc · NASDAQ
40,880,000 sh · $37.2M
Filed 30 Jun 2026SEC 13Fview source
Oaktree Capital Management
Amphastar Pharmaceuticals Inc · NASDAQ
40,880,000 sh · $37.2M
Oaktree Capital Management
Amphastar Pharmaceuticals Inc · NASDAQ
38,036,000 sh · $34.5M
Oaktree Capital Management
Amphastar Pharmaceuticals Inc · NASDAQ
43,578,000 sh · $40.4M
Oaktree Capital Management
Amphastar Pharmaceuticals Inc · NASDAQ
17,825,000 sh · $16.2M